Should We Use Renin-Angiotensin-Aldosterone System Inhibitors Routinely in Patients With Hypertrophic Cardiomyopathy?
作者信息
Park Jae-Hyeong
机构信息
Department of Cardiology in Internal Medicine, Chungnam National University, School of Medicine, Chungnam National University Hospital, Daejeon, Korea.
出版信息
Korean Circ J. 2023 Sep;53(9):619-620. doi: 10.4070/kcj.2023.0161.
Abstract
摘要
相似文献
1
Should We Use Renin-Angiotensin-Aldosterone System Inhibitors Routinely in Patients With Hypertrophic Cardiomyopathy?我们应该对肥厚型心肌病患者常规使用肾素-血管紧张素-醛固酮系统抑制剂吗？
Korean Circ J. 2023 Sep;53(9):619-620. doi: 10.4070/kcj.2023.0161.
2
Further studies needed before using renin-angiotensin-aldosterone system blockade for atrial fibrillation prevention in hypertrophic cardiomyopathy.
Heart. 2018 Dec;104(23):1985. doi: 10.1136/heartjnl-2018-313929.
3
Reply: further studies needed before using renin-angiotensin-aldosterone system blockade for atrial fibrillation prevention in hypertrophic cardiomyopathy.回复：在肥厚型心肌病中使用肾素-血管紧张素-醛固酮系统阻滞剂预防心房颤动之前，还需要进一步研究。
Heart. 2018 Dec;104(23):1985-1986. doi: 10.1136/heartjnl-2018-314000.
4
Effects of Renin-Angiotensin-Aldosterone System Inhibition on Left Ventricular Hypertrophy, Diastolic Function, and Functional Status in Patients With Hypertrophic Cardiomyopathy: A Systematic Review.肾素-血管紧张素-醛固酮系统抑制对肥厚型心肌病患者左心室肥厚、舒张功能及功能状态的影响：一项系统评价
Cureus. 2022 Jul 7;14(7):e26642. doi: 10.7759/cureus.26642. eCollection 2022 Jul.
5
Renin-angiotensin-aldosterone blockade reduces atrial fibrillation in hypertrophic cardiomyopathy.肾素-血管紧张素-醛固酮阻断减少肥厚型心肌病中的心房颤动。
Heart. 2018 Aug;104(15):1276-1283. doi: 10.1136/heartjnl-2017-312573. Epub 2018 Jan 25.
6
Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.使用培多美索治疗可降低慢性肾脏病和肾素-血管紧张素系统抑制剂治疗高钾血症患者的醛固酮水平。
Kidney Int. 2016 Sep;90(3):696-704. doi: 10.1016/j.kint.2016.04.019. Epub 2016 Jun 24.
7
Evaluation of laboratory disturbance risk when adding low-dose cotrimoxazole for PJP prophylaxis to regimens of high-grade glioma patients taking RAAS inhibitors.在服用RAAS抑制剂的高级别胶质瘤患者的治疗方案中添加低剂量复方新诺明用于预防肺孢子菌肺炎时实验室干扰风险的评估。
J Oncol Pharm Pract. 2019 Sep;25(6):1366-1373. doi: 10.1177/1078155218792985. Epub 2018 Aug 19.
8
[Plasma renin activity and aldosterone concentration of patients with congestive cardiomyopathy].
Ter Arkh. 1986;58(11):65-7.
9
New approaches to hyperkalemia in patients with indications for renin angiotensin aldosterone inhibitors: Considerations for trial design and regulatory approval.针对有使用肾素-血管紧张素-醛固酮抑制剂指征患者的高钾血症新疗法：试验设计与监管批准的考量
Int J Cardiol. 2016 Aug 1;216:46-51. doi: 10.1016/j.ijcard.2016.04.127. Epub 2016 Apr 19.
10
Evaluation of Vasopressin for Septic Shock in Patients on Chronic Renin-Angiotensin-Aldosterone System Inhibitors.慢性肾素-血管紧张素-醛固酮系统抑制剂治疗的脓毒性休克患者使用血管加压素的评估
Crit Care Med. 2017 Dec;45(12):e1226-e1232. doi: 10.1097/CCM.0000000000002729.
本文引用的文献
1
Prognostic and Safety Implications of Renin-Angiotensin-Aldosterone System Inhibitors in Hypertrophic Cardiomyopathy: A Real-World Observation Over 2,000 Patients.肾素-血管紧张素-醛固酮系统抑制剂在肥厚型心肌病中的预后及安全性影响：对2000余例患者的真实世界观察
Korean Circ J. 2023 Sep;53(9):606-618. doi: 10.4070/kcj.2023.0035.
2
Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Treatment.韩国心力衰竭管理学会心力衰竭指南：治疗
Korean Circ J. 2023 Apr;53(4):217-238. doi: 10.4070/kcj.2023.0047.
3
Different clinical characteristics and outcomes of hypertrophic cardiomyopathy with and without hypertension: seeking the truth.有高血压和无高血压的肥厚型心肌病的不同临床特征及预后：探寻真相
J Geriatr Cardiol. 2023 Feb 28;20(2):109-120. doi: 10.26599/1671-5411.2023.02.007.
4
Major Clinical Issues in Hypertrophic Cardiomyopathy.肥厚型心肌病的主要临床问题
Korean Circ J. 2022 Aug;52(8):563-575. doi: 10.4070/kcj.2022.0159.
5
Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review.肥厚型心肌病的管理：美国心脏病学会的最新综述。
J Am Coll Cardiol. 2022 Feb 1;79(4):390-414. doi: 10.1016/j.jacc.2021.11.021.
6
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial.缬沙坦治疗早期肥厚型心肌病：一项随机 2 期临床试验。
Nat Med. 2021 Oct;27(10):1818-1824. doi: 10.1038/s41591-021-01505-4. Epub 2021 Sep 23.
7
Genetics of Cardiomyopathy: Clinical and Mechanistic Implications for Heart Failure.心肌病的遗传学：对心力衰竭的临床及机制影响
Korean Circ J. 2021 Oct;51(10):797-836. doi: 10.4070/kcj.2021.0154. Epub 2021 Jul 22.
Zotero 插件